DrugPatentWatch Database Preview
Profile for South Korea Patent: 20030040552
US Patent Family Members and Approved Drugs for South Korea Patent: 20030040552
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 19, 2021 | Eisai Inc | LENVIMA | lenvatinib mesylate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |